165 related articles for article (PubMed ID: 2863016)
21. Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity.
Jung RT; Campbell RG; James WP; Callingham BA
Lancet; 1982 May; 1(8280):1043-6. PubMed ID: 6122854
[TBL] [Abstract][Full Text] [Related]
22. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers.
Casanueva FF; Borras CG; Burguera B; Lima L; Muruais C; Tresguerres JA; Devesa J
Clin Endocrinol (Oxf); 1987 Nov; 27(5):517-23. PubMed ID: 2897260
[TBL] [Abstract][Full Text] [Related]
24. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
[TBL] [Abstract][Full Text] [Related]
25. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
26. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH
Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949
[TBL] [Abstract][Full Text] [Related]
27. The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome.
Gennarelli G; Holte J; Stridsberg M; Niklasson F; Berne C; Bäckström T
Clin Endocrinol (Oxf); 1997 Feb; 46(2):167-74. PubMed ID: 9135698
[TBL] [Abstract][Full Text] [Related]
28. The effect of calcitonin on growth hormone secretion in man.
Looij BJ; Roelfsema F; van der Heide D; Frölich M; Souverijn JH; Nieuwenhuijzen Kruseman AC
Clin Endocrinol (Oxf); 1988 Nov; 29(5):517-27. PubMed ID: 2908103
[TBL] [Abstract][Full Text] [Related]
29. The effect of enkephalin analogue on pituitary hormone release in human obesity.
Finer N; Price P; Grossman A; Besser GM
Horm Metab Res; 1987 Feb; 19(2):68-70. PubMed ID: 3104184
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
[TBL] [Abstract][Full Text] [Related]
31. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine.
Argenio GF; Bernini GP; Sgró M; Vivaldi MS; Del Corso C; Santoni R; Franchi F
Metabolism; 1991 Jul; 40(7):724-7. PubMed ID: 1870427
[TBL] [Abstract][Full Text] [Related]
32. Effects of a fragment of human growth hormone-releasing factor in normal and 'Little' mice.
Clark RG; Robinson IC
J Endocrinol; 1985 Jul; 106(1):1-5. PubMed ID: 2862212
[TBL] [Abstract][Full Text] [Related]
33. Impaired hypothalamic control of prolactin secretion in massive obesity.
Kopelman PG; White N; Pilkington TR; Jeffcoate SL
Lancet; 1979 Apr; 1(8119):747-50. PubMed ID: 85990
[TBL] [Abstract][Full Text] [Related]
34. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity.
Weaver JU; Noonan K; Kopelman PG
Clin Endocrinol (Oxf); 1991 Jul; 35(1):97-102. PubMed ID: 1889145
[TBL] [Abstract][Full Text] [Related]
35. Serum growth hormone response to growth hormone-releasing hormone in non-obese and obese adults with hypopituitarism.
Bing-You RG; Bigos ST; Oppenheim DS
Metabolism; 1993 Jun; 42(6):790-4. PubMed ID: 8510526
[TBL] [Abstract][Full Text] [Related]
36. Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects.
Giustina A; Bodini C; Bossoni S; Doga M; Girelli A; Pizzocolo G; Wehrenberg WB
Clin Endocrinol (Oxf); 1990 Sep; 33(3):375-80. PubMed ID: 2147598
[TBL] [Abstract][Full Text] [Related]
37. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
[TBL] [Abstract][Full Text] [Related]
38. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F
Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of insulin- and proinsulin-induced hypoglycemia on pituitary hormone and catecholamine secretion.
Williams TC; Berelowitz M; Berk MA; Frohman LA
Diabetes Care; 1987; 10(3):278-85. PubMed ID: 3109862
[TBL] [Abstract][Full Text] [Related]
40. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
